| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Erick H Turner, Aaron D Blackwel. 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Medical hypotheses. vol 65. issue 1. 2005-08-16. PMID:15893130. |
5-hydroxytryptophan plus ssris for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. |
2005-08-16 |
2023-08-12 |
Not clear |
| Erick H Turner, Aaron D Blackwel. 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Medical hypotheses. vol 65. issue 1. 2005-08-16. PMID:15893130. |
studies have shown that selective serotonin reuptake inhibitors (ssris) can effectively treat ifn-induced depression in only 63-75% of cases. |
2005-08-16 |
2023-08-12 |
Not clear |
| Erick H Turner, Aaron D Blackwel. 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Medical hypotheses. vol 65. issue 1. 2005-08-16. PMID:15893130. |
emerging evidence indicates that ifn may cause depression by affecting brain serotonin. |
2005-08-16 |
2023-08-12 |
Not clear |
| Sanjit K Bhogal, Robert Teasell, Norine Foley, Mark Speechle. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. Journal of the American Geriatrics Society. vol 53. issue 6. 2005-08-16. PMID:15935033. |
heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. |
2005-08-16 |
2023-08-12 |
Not clear |
| Solisbella Peña, Edith Baccichet, Mary Urbina, Isabel Carreira, Lucimey Lim. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients. International immunopharmacology. vol 5. issue 6. 2005-08-15. PMID:15829422. |
effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients. |
2005-08-15 |
2023-08-12 |
human |
| Solisbella Peña, Edith Baccichet, Mary Urbina, Isabel Carreira, Lucimey Lim. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients. International immunopharmacology. vol 5. issue 6. 2005-08-15. PMID:15829422. |
mirtazapine, not being a serotonin reuptake inhibitor, did increase the number of transporters in lymphocytes of major depression patients, indicating a complex mechanism, not only directly related to the transporter, but involved in the therapeutic response. |
2005-08-15 |
2023-08-12 |
human |
| Mostafa El Mansari, Connie Sánchez, Guy Chouvet, Bernard Renaud, Nasser Haddjer. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 30. issue 7. 2005-08-09. PMID:15702136. |
these results suggest that the time course of the gradual return of presumed 5-ht neuronal firing activity, which was reported to account for the delayed effect of ssri on 5-ht transmission, is congruent with the earlier onset of action of escitalopram vs citalopram in validated animal models of depression and anxiety. |
2005-08-09 |
2023-08-12 |
rat |
| Wei Cai, Vladimir I Khaoustov, Qing Xie, Tianhong Pan, Weidong Le, Boris Yoff. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. Journal of hepatology. vol 42. issue 6. 2005-08-09. PMID:15885359. |
interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. |
2005-08-09 |
2023-08-12 |
Not clear |
| Andrew B Newberg, Jay D Amsterdam, Nancy Wintering, Karl Ploessl, Randel L Swanson, Justine Shults, Abass Alav. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 46. issue 6. 2005-08-09. PMID:15937308. |
123i-adam binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. |
2005-08-09 |
2023-08-12 |
Not clear |
| Ph D A Treffers, M A W Rinne-Alber. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression]. Nederlands tijdschrift voor geneeskunde. vol 149. issue 24. 2005-08-09. PMID:16008032. |
[selective serotonin reuptake inhibitors (ssri's) are not indicated for children and adolescents with depression]. |
2005-08-09 |
2023-08-12 |
Not clear |
| Ph D A Treffers, M A W Rinne-Alber. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression]. Nederlands tijdschrift voor geneeskunde. vol 149. issue 24. 2005-08-09. PMID:16008032. |
the efficacy of selective serotonin reuptake inhibitors (ssri's) for the treatment of depression in children and adolescents has not been demonstrated. |
2005-08-09 |
2023-08-12 |
Not clear |
| Pirjo Irmeli Saarinen, Johannes Lehtonen, Mikko Joensuu, Tommi Tolmunen, Pasi Ahola, Ritva Vanninen, Jyrki Kuikka, Jari Tiihone. An outcome of psychodynamic psychotherapy: a case study of the change in serotonin transporter binding and the activation of the dream screen. American journal of psychotherapy. vol 59. issue 1. 2005-08-08. PMID:15895769. |
we explored the outcome of psychodynamic psychotherapy of a female patient with major depression using clinical evaluation and serotonin transporter (sert) binding assessed with [123i]nor-beta-cit spect. |
2005-08-08 |
2023-08-12 |
Not clear |
| Heinz Grunz. Reevaluating therapies for bipolar depression. The Journal of clinical psychiatry. vol 66 Suppl 5. 2005-08-08. PMID:16038598. |
this advice prevails despite data showing that antidepressants are effective in treating bipolar depression and evidence that coadministration of a mood-stabilizing medication, at least with modern antidepressants, such as the selective serotonin reuptake inhibitors, can reduce the risk of treatment-emergent mania to levels comparable with those observed with mood stabilizer monotherapy. |
2005-08-08 |
2023-08-12 |
Not clear |
| Lakshmi N Yatham, Jeffrey M Goldstein, Eduard Vieta, Charles L Bowden, Heinz Grunze, Robert M Post, Trisha Suppes, Joseph R Calabres. Atypical antipsychotics in bipolar depression: potential mechanisms of action. The Journal of clinical psychiatry. vol 66 Suppl 5. 2005-08-08. PMID:16038601. |
"conventional" antidepressants, such as the selective serotonin reuptake inhibitors (ssris), bupropion, or serotonin-norepinephrine reuptake inhibitors, are not recommended as monotherapy for bipolar depression. |
2005-08-08 |
2023-08-12 |
Not clear |
| Giuseppe Guaiana, Margherita Andretta, Letizia Corbari, Mersia Mirandola, Adriano Sorio, Barbara D'Avanzo, Corrado Barbu. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. The Journal of clinical psychiatry. vol 66. issue 6. 2005-08-04. PMID:15960569. |
this study investigated the impact of the increasing consumption of selective serotonin reuptake inhibitors (ssris) and newer anti-depressants on the following public health indicators: (1) suicide rates, (2) proportion of completed suicides by poisoning with solid or liquid substances, and (3) hospital admissions for depression and proportion of admissions for depression that were first admissions. |
2005-08-04 |
2023-08-12 |
Not clear |
| Manilal Gad. Treatment of depression with the serotonin reuptake enhancer tianeptine in the primary care setting of India. Journal of the Indian Medical Association. vol 103. issue 2. 2005-08-04. PMID:16008321. |
treatment of depression with the serotonin reuptake enhancer tianeptine in the primary care setting of india. |
2005-08-04 |
2023-08-12 |
Not clear |
| Manilal Gad. Treatment of depression with the serotonin reuptake enhancer tianeptine in the primary care setting of India. Journal of the Indian Medical Association. vol 103. issue 2. 2005-08-04. PMID:16008321. |
the aim of this study was to evaluate the efficacy and compliance of tianeptine, a selective serotonin reuptake enhancer (ssre), for the treatment of major depression in primary care setting of india. |
2005-08-04 |
2023-08-12 |
Not clear |
| H J Möller, M Bauer, J Fritze, E Haen, G Laux, W E Müller, E Rüthe. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]. MMW Fortschritte der Medizin. vol 147. issue 3. 2005-08-03. PMID:15727113. |
[selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]. |
2005-08-03 |
2023-08-12 |
Not clear |
| H J Möller, M Bauer, J Fritze, E Haen, G Laux, W E Müller, E Rüthe. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]. MMW Fortschritte der Medizin. vol 147. issue 3. 2005-08-03. PMID:15727113. |
with the tricyclics, selective serotonin reuptake inhibitors (ssris) and other substances, we now have available a range of medications for the treatment of depression and other psychological disorders (e.g. |
2005-08-03 |
2023-08-12 |
Not clear |
| Liborio Rampello, Alessandro Alvano, Santina Chiechio, Rocco Raffaele, Ignazio Vecchio, Mariano Malaguarner. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study. Archives of gerontology and geriatrics. vol 40. issue 3. 2005-08-02. PMID:15814161. |
although selective serotonin reuptake inhibitors (ssri) are often used in post-stroke depression (psd), it has been observed that only a subset of patients is responsive to this treatment. |
2005-08-02 |
2023-08-12 |
Not clear |